|
|
Biopolis Québec' Founding Partners
 |
The life sciences and health
technologies cluster of
Metropolitan Montréal
 Montréal InVivo, a non-profit organization, is the brand name for the life sciences and health technologies cluster of the Montréal metropolitan area.
 The cluster is comprised of more than 620 organizations, including 150 research organizations, and 80 subsidiaries of foreign companies. It is a fertile breeding ground for innovation and creativity.
 Montréal InVivo’s operating costs are among the lowest in North America in the fields of the life sciences and health technologies. The cluster is also unique in Canada, and is one of the few places in the world, where a company can conduct every phase of creation of a new drug, from basic research through to commercialization. The cluster provides a productive environment for every company in the life sciences and health technologies.
The Montréal InVivo cluster is one of the larger metropolitan areas in North America as far as employment is concerned, with over 41,000 qualified people employed.
This creative cluster is supported by 11 institutions of higher education and it is ranked 1st in Canada in terms of the number of research centres and total university research funding.
Greater Montréal is ranked 1st in North America in terms of the number of university students per capita. It is, without a doubt, a talent incubator in which discovery thrives.
www.montreal-invivo.com |
| |
|
 |
|
| |
|
 |
Perfect Proximity, Infinite Vision….
The Life Sciences cluster is an undeniable force in Sherbrooke, with strengths ranging from drug discovery to medical technologies. Companies, researchers, and institutions combine to create a world-class cluster in Sherbrooke, a driving force for the growth of Life Sciences.
Sherbrooke’s assets in Life Sciences secure the region a favourable competitive position worldwide in this booming sector! At the core of the Life Sciences regional cluster and a major hub for research centers, technology platforms, and complementary businesses, Sherbrooke is a prime location for research.
The concentration of key players within Sherbrooke is conducive to carrying out comprehensive research projects, from fundamental or applied research to product commercialization, including preclinical and clinical research: a unique characteristic and a sizeable advantage! Furthermore, leading companies and research centers belonging to the University Pole in Sherbrooke—in particular the Institut interdisciplinaire d’innovation technologique (3IT- Interdisciplinary Institute
for Technological Innovation), the Research Centre on Aging (CDRV), and Étienne-Le Bel Clinical Research Centre (CRCELB)—play a major role in the rapid and continuous developments and advances in medical technologies. Last June, Estrie and its capital city, Sherbrooke, were recognized as Biotech Health niches of excellence within the Quebec Government’s ACCORD program. Suffice it to say, all elements are firmly in place for the city to continue to support research and development in Life Sciences.
Specialties
Strengths
Leaders
www.sherbrooke-innopole.com |
| |
|
|
|
| |
|
 |
A booming industry in Québec City's
metropolitan region
With a state-of-the-art expertise in biopharmaceuticals, diagnostics, natural health products (cosmeceuticals and nutraceuticals), medical technologies and information technologies related to health, the Québec City metropolitan region is ideally positioned for a growing market. The global market of pharmaceutical products alone should double before 2020 to reach CDN $1.8 billion (PricewaterhouseCoopers 2010)-and the life sciences industry in the Québec City metropolitan region is set to reap the benefits.
Leaders with state-of-the-art expertise
The Québec City metropolitan region is distinguished by leaders and innovative companies with state-of-the-art expertise:
- Biopharmaceuticals and diagnostics : Æterna Zentaris, Anapharm-Pharmanet, BD GeneOhm, Diagnocure, GlaxoSmithKline and Medicago
- Medical and health information technologies : Carefusion Canada, Myca, Orthofab, Steris Corporation and Stryker
- Natural health and wellness products : Advitech, Atrium, Bain Ultra, Dectro International, Epiderma, Immanence Dermo Correction, Nutra Canada and  Unipex
Key university hospital research centers
Investing in a favourable business environment
With a thriving life sciences industry, the Québec City metropolitan region benefits from ongoing and future investments (2010):
- Expansion and renovation of Hôtel-Dieu Hospital, Québec City - CDN $635 million
- Modernization of vaccine production facility, GSK - $90 M CA GSK - CDN $90 million
- New R&D Center and production facility, BD GeneOhm - CDN $50 million
- Otto Bock / Victhom Human Bionics - CDN $30 million
- Obesity research laboratories, CRIUCPQ - CDN $28 million
According to KPMG's 2010 Competitive Alternatives report, operating costs in the Québec City metropolitan region are lower than the average for North American cities in clinical trials (27%), biomedical R&D (20%) and manufacturing pharmaceuticals (6 %)-making it #1 in Canada and the United States.
The Québec City metropolitan region has a lot to offer. To find out more, read our brochure Invest in the Quebec City metropolitan region or the Choose Québec section to learn more :
www.quebecinternational.ca |
|
In Québec - 6 major universities (4 with medical schools)
|
